Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

498 - Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.

Date

21 Oct 2018

Session

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

Topics

Cancer Biology

Tumour Site

Hepatobiliary Cancers

Presenters

Xiao Fu

Citation

Annals of Oncology (2018) 29 (suppl_8): viii1-viii13. 10.1093/annonc/mdy268

Authors

X. Fu1, M. Liu1, S. Qu1, J. Ma1, Y. Zhang1, T. Shi1, H. Wen1, Y. Yang2, S. Wang1, J. Wang1, K. Nan1, Y. Yao1, T. Tian1

Author affiliations

  • 1 Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University (School of Medicine), 710061 - Xi'an/CN
  • 2 The Third Department Of Cardiology, Shaanxi Provincial People's Hospital, 710068 - Xi'an/CN

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 498

Background

Multidrug resistance is the main obstacle for hepatocellular carcinoma (HCC) treatment. Through bioinformatics prediction, literature review, and real-time PCR, we found that elevated miR-32-5p was associated with tumorigenesis in different cancer types, including HCC. miR-32-5p also contributes to castration resistance, radioresistance and chemoresistance in prostate cancer, but its function in multidrug resistance is still unclear. Exosomes are the most abundant type of extracellular vehicles (EVs), containing RNAs (especially miRs), proteins and other bioactive molecules. Recently, exosomes generated from chemoresistant cells have been proven to deliver miRs and transfer malignant phenotype to sensitive cells. Here we aim to find out the function of miR-32-5p in inducing multidrug resistance and the possible underlying mechanisms.

Methods

We detected the expression of miR-32-5p and PTEN in the cells and exosomes from both the multidrug-resistant and the sensitive cell lines, HCC and para-carcinoma liver tissues through real-time PCR. Dual-luciferase reporter assay verified PTEN is the target of miR-32-5p. Exosomes were obtained and confirmed through ultracentrifuge and Nano Analyzer. Gain- and loss-of-function experiments, rescue experiments, an exosome biogenesis inhibitor, and nude mice xenograft models were used to determine the underlying mechanisms of miR-32-5p and PTEN, as well as exosomal miR-32-5p in inducing multidrug resistance in vitro and in vivo.

Results

miR-32-5p was significantly elevated in multidrug-resistant HCC cell line, Bel/5-FU as well as the exosomes derived from Bel/5-FU. An inverse correlation between miR-32-5p and PTEN was confirmed in HCC cell lines and patients; moreover, high expression of miR-32-5p and low expression of PTEN were positively associated with poor prognosis. Both in vitro and in vivo expriments reveal that exosomal miR-32-5p leads to multidrug resistance by targeting PTEN and activating the PI3K/Akt pathway through promoting EMT and angiogenesis.

Conclusions

Our study demonstrated that the multidrug-resistant cell, Bel/5-FU delivers miR-32-5p to sensitive cell, Bel7402 by exosome and activates the PI3K/Akt pathway to further induce multidrug resistance by modulating angiogenesis and EMT.

Clinical trial identification

Legal entity responsible for the study

The First Affiliated Hospital of Xi'an Jiaotong University.

Funding

National Natural Science Foundation of China (No. 81301909 and 81672810). International cooperation project in science and technology of Shaanxi province (No. 2016KW-017). Natural Science Foundation of Shaanxi Province (No.2017JM8019).

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.